Arcellx Company
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Investors
Technology:
CAR-T, CAR-T therapy
Industry:
CAR-T, Public
Headquarters:
Gaithersburg, Maryland, United States
Founded Date:
2015-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
25
Total Funding:
421999986
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-12-09
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership